Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses

• Ngā kaituhi matua: Qiliang Yin (Author), Ying Wang (Author), Yipeng Xiang (Author), Feng Xu (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

An attractive type of cancer immunotherapy is cancer therapeutic vaccines that induce antitumor immunity effectively. Although supportive results in the recent vaccine studies, there are still numerous drawbacks, such as poor stability, weak immunogenicity and strong toxicity, to be tackled for prom...